| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lifecore Biomedical, Inc. \de\ (LFCR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. LFCR is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 336.7K | $1.63M | - | |
| Dir | 164.1K | $794.2K | - | |
| Dir | 135.3K | $654.9K | - | |
| Dir | 133.1K | $644.1K | - | |
| Dir | 73.0K | $353.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 9, 2018 | Midyett Ronald Lane | Chief Operations Officer | Sell | 9,239 | $13.36 | $123,433.04 | -13.6% | |
| Apr 25, 2018 | Midyett Ronald Lane | Chief Operations Officer | Sell | 163 | $13.85 | $2,257.55 | -0.2% | |
| Apr 20, 2018 | Midyett Ronald Lane | Chief Operations Officer | Sell | 4,631 | $13.88 | $64,255.64 | -3.3% | |
| Apr 18, 2018 | Midyett Ronald Lane | Chief Operations Officer | Sell | 13,450 | $13.93 | $187,325.68 | -7.8% | |
| Apr 6, 2018 | Midyett Ronald Lane | Chief Operations Officer | Sell | 2,517 | $14.02 | $35,288.34 | -2.8% | |
| Oct 24, 2017 | Hemmeter Molly | Chief Executive Officer | Sell | 7,399 | $13.06 | $96,658.94 | -7.0% | |
| May 10, 2017 | Steele Gary T | Director | Sale+OE | 26,708 | $14.00 | $373,912.00 | -24.4% | |
| May 10, 2017 | Steele Gary T | Director | Sale+OE | 26,708 | $14.00 | $373,912.00 | -24.4% | |
| Apr 11, 2017 | Midyett Ronald Lane | Chief Operations Officer | Sell | 20,000 | $13.76 | $275,200.00 | -19.1% | |
| Apr 11, 2017 | Frank Fred | Director | Sell | 3,025 | $14.00 | $42,350.00 | -6.8% |